Fully integrated full service CRO providing services across the drug discovery & development pipeline.
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
75
NCT06178055
A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 16, 2024
Completion: Dec 31, 2025
Loading map...